EP1597318A4 - Poloxamer emulsion preparations - Google Patents

Poloxamer emulsion preparations

Info

Publication number
EP1597318A4
EP1597318A4 EP04712958A EP04712958A EP1597318A4 EP 1597318 A4 EP1597318 A4 EP 1597318A4 EP 04712958 A EP04712958 A EP 04712958A EP 04712958 A EP04712958 A EP 04712958A EP 1597318 A4 EP1597318 A4 EP 1597318A4
Authority
EP
European Patent Office
Prior art keywords
poloxamer
emulsion preparations
preparations
emulsion
poloxamer emulsion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP04712958A
Other languages
German (de)
French (fr)
Other versions
EP1597318A1 (en
Inventor
Steen Boye Jorsal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novasel Australia Pty Ltd
Original Assignee
Novasel Australia Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novasel Australia Pty Ltd filed Critical Novasel Australia Pty Ltd
Publication of EP1597318A1 publication Critical patent/EP1597318A1/en
Publication of EP1597318A4 publication Critical patent/EP1597318A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A61K8/068—Microemulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/90—Block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
    • C08L71/02—Polyalkylene oxides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G2650/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G2650/28—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule characterised by the polymer type
    • C08G2650/58—Ethylene oxide or propylene oxide copolymers, e.g. pluronics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Colloid Chemistry (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP04712958A 2003-02-27 2004-02-20 Poloxamer emulsion preparations Withdrawn EP1597318A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2003900887 2003-02-27
AU2003900887A AU2003900887A0 (en) 2003-02-27 2003-02-27 Poloxamer emulsion preparations
PCT/AU2004/000218 WO2004076561A1 (en) 2003-02-27 2004-02-20 Poloxamer emulsion preparations

Publications (2)

Publication Number Publication Date
EP1597318A1 EP1597318A1 (en) 2005-11-23
EP1597318A4 true EP1597318A4 (en) 2006-06-14

Family

ID=31499933

Family Applications (1)

Application Number Title Priority Date Filing Date
EP04712958A Withdrawn EP1597318A4 (en) 2003-02-27 2004-02-20 Poloxamer emulsion preparations

Country Status (9)

Country Link
EP (1) EP1597318A4 (en)
JP (1) JP2006519272A (en)
CN (1) CN100591721C (en)
AU (3) AU2003900887A0 (en)
BR (1) BRPI0408056A (en)
CA (1) CA2516863C (en)
EA (1) EA017434B1 (en)
NO (1) NO20054395L (en)
WO (1) WO2004076561A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9132087B2 (en) * 2008-04-21 2015-09-15 Otonomy, Inc. Auris formulations for treating otic diseases and conditions
WO2010076730A1 (en) * 2009-01-02 2010-07-08 Donald, Jenny Method for the treatment of an hiv infection
KR101792200B1 (en) * 2010-04-01 2017-10-31 파마네스트 아베 Thermogelling anaesthetic compositions
LT2689774T (en) * 2011-03-21 2019-03-25 Broda Technologies Co., Ltd Reversely thermo-reversible hydrogel compositions
ITMI20131927A1 (en) 2013-11-20 2015-05-21 Cosmo Technologies Ltd EMULSIONS OR MICROEMULSIONS FOR USE IN ENDOSCOPIC MUCOSAL RESECTIONING AND / OR ENDOSCOPIC SUBMUCOSAL DISSECTION. EMULSIONS OR MICROEMULSIONS FOR USE IN ENDOSCOPIC MUCOSAL RESECTION AND / OR ENDOSCOPIC SUBMUCOSAL DISSECTION
MX2016012288A (en) * 2014-03-25 2017-01-23 Genentech Inc Methods of preparing a poloxamer for use in cell culture medium.
US10351750B2 (en) * 2017-02-03 2019-07-16 Saudi Arabian Oil Company Drilling fluid compositions with enhanced rheology and methods of using same
KR101852718B1 (en) * 2017-04-04 2018-05-18 주식회사 제네웰 Kit for pain reduction of incision site after surgical operation
SG11202002351SA (en) * 2017-12-21 2020-07-29 Sigma Aldrich Co Llc Poloxamer compositions and methods of making and using same
IT201900018752A1 (en) * 2019-10-14 2021-04-14 Alessandro Tosetti COMPOSITION BASED ON ESSENTIAL OILS FOR DENTAL USE FOR THE TREATMENT OF PERIODONTITIS AND PERIMPLANT MUCOSITE
RU2762506C1 (en) * 2021-01-20 2021-12-21 Общество С Ограниченной Ответственностью «Диамед-Фарма» Agent for applying oral and nasal cavities and method for its use as part of complex therapy of infectious and inflammatory diseases of nasal and oral cavities
CN114455621B (en) * 2022-01-11 2023-10-27 兰州交通大学 Preparation method of needle-shaped calcium carbonate

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990003429A1 (en) * 1988-09-23 1990-04-05 Cetus Corporation Lipid microemulsions for culture media
US5698219A (en) * 1994-08-08 1997-12-16 Laboratorios Cusi, S.A. Nanoemulsion of the oil water type, useful as an ophthalmic vehicle and process for the preparation thereof
DE19723308A1 (en) * 1997-06-04 1998-12-10 Wolfgang A Prof Dr Wohlrab Microemulsions useful for topical administration of e.g. local anaesthetics
US5952004A (en) * 1994-03-18 1999-09-14 Shire Laboratories Inc. Emulsified drug delivery systems
EP1018363A1 (en) * 1999-01-05 2000-07-12 L'oreal Nanoemulsion based on sequenced copolymers of ethylene oxyde and propylene oxyde and uses thereof in the fields of cosmetics, dermatology and/or ophthalmology
WO2000051550A1 (en) * 1999-03-01 2000-09-08 Basf Corporation Cold processed water-in-oil emulsions
WO2000078301A1 (en) * 1999-06-21 2000-12-28 Kuhnil Pharm. Co., Ltd. Anesthetic composition for intravenous injection comprising propofol
WO2001066087A1 (en) * 2000-03-08 2001-09-13 Astrazeneca Ab New self emulsifying drug delivery system
WO2002009671A2 (en) * 2000-08-01 2002-02-07 University Of Florida Microemulsion and micelle systems for solubilizing drugs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0791555B2 (en) * 1989-12-22 1995-10-04 株式会社資生堂 Cleaning composition
SE9601421D0 (en) * 1996-04-12 1996-04-12 Astra Ab New composition

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990003429A1 (en) * 1988-09-23 1990-04-05 Cetus Corporation Lipid microemulsions for culture media
US5952004A (en) * 1994-03-18 1999-09-14 Shire Laboratories Inc. Emulsified drug delivery systems
US5698219A (en) * 1994-08-08 1997-12-16 Laboratorios Cusi, S.A. Nanoemulsion of the oil water type, useful as an ophthalmic vehicle and process for the preparation thereof
DE19723308A1 (en) * 1997-06-04 1998-12-10 Wolfgang A Prof Dr Wohlrab Microemulsions useful for topical administration of e.g. local anaesthetics
EP1018363A1 (en) * 1999-01-05 2000-07-12 L'oreal Nanoemulsion based on sequenced copolymers of ethylene oxyde and propylene oxyde and uses thereof in the fields of cosmetics, dermatology and/or ophthalmology
WO2000051550A1 (en) * 1999-03-01 2000-09-08 Basf Corporation Cold processed water-in-oil emulsions
WO2000078301A1 (en) * 1999-06-21 2000-12-28 Kuhnil Pharm. Co., Ltd. Anesthetic composition for intravenous injection comprising propofol
WO2001066087A1 (en) * 2000-03-08 2001-09-13 Astrazeneca Ab New self emulsifying drug delivery system
WO2002009671A2 (en) * 2000-08-01 2002-02-07 University Of Florida Microemulsion and micelle systems for solubilizing drugs

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2004076561A1 *

Also Published As

Publication number Publication date
AU2004215921A1 (en) 2004-09-10
AU2009202265B2 (en) 2012-02-16
EA200501368A1 (en) 2006-02-24
BRPI0408056A (en) 2006-02-14
AU2009202265A1 (en) 2009-07-02
CA2516863C (en) 2011-12-06
EA017434B1 (en) 2012-12-28
CN1753949A (en) 2006-03-29
WO2004076561A1 (en) 2004-09-10
CN100591721C (en) 2010-02-24
CA2516863A1 (en) 2004-09-10
EP1597318A1 (en) 2005-11-23
NO20054395L (en) 2005-09-22
AU2003900887A0 (en) 2003-03-13
JP2006519272A (en) 2006-08-24

Similar Documents

Publication Publication Date Title
IL173808A0 (en) Pharmaceutical liposomal formulations
HK1084338A1 (en) Pharmaceutical formulation comprising lanthanum compounds
PL1687028T3 (en) Immunoglobulin preparations having increased stability
IL172824A0 (en) Pharmaceutical formulations
PL2279729T3 (en) Controlled release preparations
GB0302671D0 (en) Pharmaceutical formulations
DE502004002225D1 (en) Self-emulsifying preparations
EP1597318A4 (en) Poloxamer emulsion preparations
GB0316206D0 (en) Pharmaceutical formulation
GB0318448D0 (en) Formulation
GB0302672D0 (en) Pharmaceutical formulations
EP1369101A4 (en) Cosmetic w/o/w emulsion preparation
EP1698671A4 (en) Emulsion composition
GB0312195D0 (en) Formulation
GB0316341D0 (en) Pharmaceutical formulations
GB0320522D0 (en) Formulation
GB0316889D0 (en) Pharmaceutical agents
GB0308691D0 (en) Vaccine preparations
GB0303876D0 (en) Formulation
EP1642586A4 (en) Cell-containing preparations
GB0316335D0 (en) Pharmaceutical formulations
GB0310881D0 (en) Pharmaceutical formulation
GB0327722D0 (en) Pharmaceutical formulations
GB0326642D0 (en) Pharmaceutical formulations
GB0324912D0 (en) Pharmaceutical formulations

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050826

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

A4 Supplementary search report drawn up and despatched

Effective date: 20060428

17Q First examination report despatched

Effective date: 20060816

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1089197

Country of ref document: HK

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1089197

Country of ref document: HK

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 47/34 20170101ALI20170421BHEP

Ipc: B01F 17/42 20060101ALI20170421BHEP

Ipc: C08L 71/02 20060101AFI20170421BHEP

Ipc: A61K 9/107 20060101ALI20170421BHEP

Ipc: C08J 3/075 20060101ALI20170421BHEP

INTG Intention to grant announced

Effective date: 20170519

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20170930

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 47/34 20170101ALI20170421BHEP

Ipc: C08J 3/075 20060101ALI20170421BHEP

Ipc: A61K 9/107 20060101ALI20170421BHEP

Ipc: B01F 17/42 20060101ALI20170421BHEP

Ipc: C08L 71/02 20060101AFI20170421BHEP